Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs DOI
Farhad Sheikhnia, Ahmad Fazilat,

Vahid Rashidi

et al.

Pathology - Research and Practice, Journal Year: 2024, Volume and Issue: 260, P. 155374 - 155374

Published: May 29, 2024

Language: Английский

Long non-coding RNAs: From disease code to drug role DOI Creative Commons
Yuanyuan Chen, Zhaojun Li, Xiaoguang Chen

et al.

Acta Pharmaceutica Sinica B, Journal Year: 2020, Volume and Issue: 11(2), P. 340 - 354

Published: Oct. 10, 2020

Enormous studies have corroborated that long non-coding RNAs (lncRNAs) extensively participate in crucial physiological processes such as metabolism and immunity, are closely related to the occurrence development of tumors, cardiovascular diseases, nervous system disorders, nephropathy, other diseases. The application lncRNAs biomarkers or intervention targets can provide new insights into diagnosis treatment This paper has focused on emerging research pharmacological reviewed transition from role disease coding acting drug candidates, including current status progress preclinical research. Cutting-edge strategies for lncRNA modulation been summarized, sources lncRNA-related drugs, genetic technology small-molecule compounds, delivery methods. clinical trials lncRNA-targeting drugs is also discussed. information will form a latest updated reference lncRNA-based drugs.

Language: Английский

Citations

381

Competing Endogenous RNAs, Non-Coding RNAs and Diseases: An Intertwined Story DOI Creative Commons
Ugo Ala

Cells, Journal Year: 2020, Volume and Issue: 9(7), P. 1574 - 1574

Published: June 28, 2020

MicroRNAs (miRNAs), a class of small non-coding RNA molecules, are responsible for silencing and post-transcriptional regulation gene expression. They can mediate fine-tuned crosstalk among coding molecules sharing miRNA response elements (MREs). In suitable environment, both be targeted by the same miRNAs indirectly regulate each other competing them. These RNAs, otherwise known as endogenous RNAs (ceRNAs), lead to an additional regulatory layer, where find new significance. The miRNA-mediated interplay different types has been observed in many contexts. analyses ceRNA networks cancer pathologies, well physiological conditions, provide opportunities interpreting omics data field personalized medicine. development novel computational tools, providing putative predictions interactions, is rapidly growing interest. this review, I discuss present current knowledge mechanism its implications broad spectrum such cardiovascular or autoimmune diseases, cancers neurodegenerative disorders.

Language: Английский

Citations

149

Small molecule recognition of disease-relevant RNA structures DOI Creative Commons
Samantha M. Meyer,

Christopher C. Williams,

Yoshihiro Akahori

et al.

Chemical Society Reviews, Journal Year: 2020, Volume and Issue: 49(19), P. 7167 - 7199

Published: Jan. 1, 2020

Targeting RNAs with small molecules, a new frontier in drug discovery and development.

Language: Английский

Citations

142

Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications DOI Creative Commons

Xuehao Zhou,

Xiang Ao,

Zhaojun Jia

et al.

Frontiers in Oncology, Journal Year: 2022, Volume and Issue: 12

Published: Aug. 17, 2022

Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a serious, long-term threat to patients’ health and life. Systemic chemotherapy remains first-line therapeutic approach for recurrent or metastatic cancer patients after surgery, with potential effectively extend patient survival. However, development drug resistance seriously limits clinical efficiency ultimately results in treatment failure death. A large number studies have shown that non-coding RNAs (ncRNAs), particularly microRNAs, long RNAs, circular are widely involved regulation resistance. Their dysregulation contributes by modulating expression specific target genes cellular apoptosis, autophagy, efflux, epithelial-to-mesenchymal transition (EMT), stem cells (CSCs). Moreover, some ncRNAs also possess great as efficient, biomarkers diagnosis prognosis well targets patients. In this review, we summarize recent findings on emerging role underlying mechanisms focus their applications treatment. This information will be benefit early prognostic assessments ncRNA-based strategies

Language: Английский

Citations

79

Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review DOI
Tohada M. AL‐Noshokaty, Abdallah Mansour, Rehab Abdelhamid

et al.

Pathology - Research and Practice, Journal Year: 2023, Volume and Issue: 245, P. 154438 - 154438

Published: April 6, 2023

Language: Английский

Citations

52

Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics DOI
Nadia Μ. Hamdy, Mohamed Bakr Zaki,

Nehal I. Rizk

et al.

Life Sciences, Journal Year: 2024, Volume and Issue: 354, P. 122946 - 122946

Published: Aug. 8, 2024

Language: Английский

Citations

24

Oxidative stress and dysregulated long noncoding RNAs in the pathogenesis of Parkinson’s disease DOI Creative Commons
Jialu Wang,

Meitong Liu,

Jiuhan Zhao

et al.

Biological Research, Journal Year: 2025, Volume and Issue: 58(1)

Published: Jan. 27, 2025

Parkinson's disease (PD) is a progressive age-related neurodegenerative whose annual incidence increasing as populations continue to age. Although its pathogenesis has not been fully elucidated, oxidative stress shown play an important role in promoting the occurrence and development of disease. Long noncoding RNAs (lncRNAs), which are more than 200 nucleotides length, also involved PD at transcriptional level via epigenetic regulation, or post-transcriptional by participating physiological processes, including aggregation α-synuclein, mitochondrial dysfunction, stress, calcium stabilization, neuroinflammation. LncRNAs correlated during processes: affects expression multiple lncRNAs, while lncRNAs regulate many genes responses. Oxidative affect other processes associated with neurodegeneration, dysfunction increased neuroinflammation that lead neuronal death. Therefore, modulating levels specific may alleviate pathological damage have neuroprotective effects. This review discusses general mechanisms mechanism underlying PD, teases out through pathogenesis, well identifies possible lncRNAs. Reviewing published studies will help us further understand process identify potential therapeutic strategies for PD.

Language: Английский

Citations

4

Long Non-Coding RNA (lncRNA) Roles in Cell Biology, Neurodevelopment and Neurological Disorders DOI Creative Commons
Vincenza Aliperti,

Justyna Skonieczna,

Andrea Cerase

et al.

Non-Coding RNA, Journal Year: 2021, Volume and Issue: 7(2), P. 36 - 36

Published: June 17, 2021

Development is a complex process regulated both by genetic and epigenetic environmental clues. Recently, long non-coding RNAs (lncRNAs) have emerged as key regulators of gene expression in several tissues including the brain. Altered lncRNAs has been linked to neurodegenerative, neurodevelopmental mental disorders. The identification characterization that are deregulated or mutated health diseases fundamental understanding transcriptional processes brain function. Crucially, can be exploited novel target for treating neurological In our review, we first summarize recent advances lncRNA functions context cell biology then discussing their association with selected neuronal development

Language: Английский

Citations

98

LncRNA H19: A novel oncogene in multiple cancers DOI Creative Commons
Jun Yang,

Manlong Qi,

Xiang Fei

et al.

International Journal of Biological Sciences, Journal Year: 2021, Volume and Issue: 17(12), P. 3188 - 3208

Published: Jan. 1, 2021

Long non-coding RNAs (lncRNAs) are a series of that lack open reading frameworks.Accumulating evidence suggests important roles for lncRNAs in various diseases, including cancers.Recently, lncRNA H19 (H19) became research focus due to its ectopic expression human malignant tumors, where it functioned as an oncogene.Subsequently, was confirmed be involved tumorigenesis and progression many tumors had been implicated promoting cell growth, invasion, migration, epithelial-mesenchymal transition, metastasis, apoptosis.H19 also sequesters some microRNAs, facilitating multilayer molecular regulatory mechanism.In this review, we summarize the abnormal overexpression cancers, which wide prospects further into diagnosis treatment cancers.

Language: Английский

Citations

98

Long Non-coding RNAs and MicroRNAs Interplay in Osteogenic Differentiation of Mesenchymal Stem Cells DOI Creative Commons

Carmen Lanzillotti,

Monica De Mattei, Chiara Mazziotta

et al.

Frontiers in Cell and Developmental Biology, Journal Year: 2021, Volume and Issue: 9

Published: April 9, 2021

Long non-coding RNAs (lncRNAs) have gained great attention as epigenetic regulators of gene expression in many tissues. Increasing evidence indicates that lncRNAs, together with microRNAs (miRNAs), play a pivotal role osteogenesis. While miRNA action mechanism relies mainly on miRNA-mRNA interaction, resulting suppressed expression, lncRNAs affect mRNA functionality through different activities, including interaction miRNAs. Recent advances RNA sequencing technology improved knowledge into the molecular pathways regulated by and This review reports recent miRNAs roles key osteogenic differentiation. Specifically, we described herein discoveries lncRNA-miRNA crosstalk during differentiation mesenchymal stem cells (MSCs) derived from bone marrow (BM), well other anatomical regions. The deep understanding connection between will strongly improve mechanisms growth development, ultimately leading to discover innovative diagnostic therapeutic tools for disorders diseases.

Language: Английский

Citations

95